Indeed, an in vitro study using GBM cell lines revealed that the expression of the μ subunit of AP5 controlled GBM cell sensitivity to Tumor Necrosis Factor Related Apoptosis-Inducing Ligand, suggesting that AP5 might be involved in the apoptosis signaling pathway triggered by anti-cancer drugs [263]. Here, AP5B1 is linked to cancer.